IMV and CRCHU de Québec-U Laval Collaboration Awarded a CQDM Grant to Develop First-in-class Dual Target T cell Therapy in Bladder Cancer Based on IMV’s DPX Technology

News & Events

Two antigens are targeted in combination with the DPX technology developed by IMV Quebec City, Quebec, March 18, 2019 – IMV Inc. (IMV) (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology corporation, today announced that Canadian bioresearch consortium CQDM has awarded a grant to a collaboration among IMV, Centre de recherche du CHU de Québec-Université Laval, and La Fondation du … Read More

Call for Applications for the Gordon Shore Prize – Internships for new graduates

News & Events

Created by CQDM, Diazon Pharmaceuticals, the Oncopole, and Mitacs, the Gordon Shore Prize is awarded to new graduates whose masters or doctoral thesis demonstrated their research excellence in the life science field. A 6-month post-diploma internship of $24,000 will be offered to each of the awardees by the participating Quebec-based companies: SpecificiT Pharma Inc., Immune Biosolutions Inc. et IMV Inc. To … Read More

Philippe Walker appointed Member of the Scientific Advisory Board of CQDM

News & Events

Montreal, January 29th, 2019. – CQDM is pleased to announce the appointment of Philippe Walker as a member of CQDM’s Scientific Advisory Board. Philippe already knows CQDM very well since he has contributed very closely to its creation and success. Philippe has over 30 years of experience in pharmaceutical research and development in several therapeutic areas. He moved to Montreal … Read More

Call for Proposal to Private Companies – Post-Diploma Internships Co-Funded through the Gordon Shore Prize

News & Events

Private companies based in Quebec with life sciences-related activities are invited to offer two 6-month post-diploma internship positions for new graduates (Masters and PhD), future awardees of the Gordon Shore Prize. The Funders of this award, CQDM, Diazon, the Oncopole and Mitacs will finance 50 % of these post-diploma internships. The company must agree to pay the other half of … Read More